Q-Med

Uppsala, Sweden Founded: 1987 • Age: 39 yrs Acquired By Galderma
Medical implants based on Non-Animal Stabilized Hyaluronic Acid for esthetics, orthopedics, urogynecology, and cell therapy.
Request Access

About Q-Med

Q-Med is a company based in Uppsala (Sweden) founded in 1987 by Manuel Aguero was acquired by Galderma in December 2011.. Q-Med operates in a competitive market with competitors including Avita Medical, Suneva Medical, LifeCell, MoMelan Technologies and Quality by Design, among others.

  • Headquarter Uppsala, Sweden
  • Founders Manuel Aguero
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Galderma

    (Dec 13, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Q-Med

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Q-Med

Q-Med has secured backing from 1 investor. Prominent investors backing the company include Galderma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Dermatological products are manufactured to treat various skin conditions.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Q-Med

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Q-Med

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Q-Med Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Q-Med

Q-Med operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avita Medical, Suneva Medical, LifeCell, MoMelan Technologies and Quality by Design, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Products for regenerative and respiratory medicine are developed and distributed.
domain founded_year HQ Location
Novel aesthetic products for regenerative markets are developed and commercialized.
domain founded_year HQ Location
Tissue repair products for regenerative medicine are developed and marketed.
domain founded_year HQ Location
Skin grafting technology for dermatological diseases and wound care
domain founded_year HQ Location
Medical grade collagen components are developed and manufactured.
domain founded_year HQ Location
Replica of human eye and Scar filler to fill skin defects
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Q-Med

Frequently Asked Questions about Q-Med

When was Q-Med founded?

Q-Med was founded in 1987.

Where is Q-Med located?

Q-Med is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.

What does Q-Med do?

Q-Med engages in the development, manufacture, marketing, and sale of medical implants for aesthetic and medical use. The companys products are based on its patented technology, NASHA, which is used to produce stabilized non-animal hyaluronic acid. Its products include (1) Restylane products for filling out wrinkles and contouring lips (2) Macrolane VRF for body shaping (3) Deflux, which is used in the treatment of vesicoureteral reflux in children (4) Durolane for the treatment of osteoarthritis of the knee and hip joints (5) Solesta for the treatment of fecal incontinence. Q-Med sells its products through subsidiaries or distributors worldwide. In 2007 Q-Med acquired Ox-thera for approximately 30M. Q-Med was acquired by Galderma for 1.8B in 2011.

Who are the top competitors of Q-Med?

Q-Med's top competitors include Avita Medical, Quality by Design and Suneva Medical.

Who are Q-Med's investors?

Q-Med has 1 investor. Key investors include Galderma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available